Combined Modality Treatment for Patients With Stage IV Melanoma
NCT00313235
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
41
Enrollment
OTHER
Sponsor class
Conditions
Malignant Melanoma Stage IV
Interventions
BIOLOGICAL:
DC Vaccine and Cyclophosphamide
Sponsor
Baylor Research Institute